Ellipsis Health, an AI care management company that sells a product called Sage, has acquired Kouper Health, a New York startup that builds AI agents for hospital and provider-group workflows. The deal was announced on November 5, 2026, in a release distributed by Business Wire.
Terms were not disclosed, and neither company said how many people work at Kouper. Kouper's team is joining Ellipsis, but both companies will keep their own brands and continue to serve their existing customers while they work on a shared product roadmap. Ellipsis said new offerings for health systems would follow in the coming months.
What Kouper built
Kouper was founded in 2022 and started with a narrow problem: what happens to patients after they leave an emergency room, an inpatient ward or an urgent-care clinic. According to HC Innovation Group, its platform was designed to keep those patients engaged, automate the scheduling of follow-up appointments and capture data that flows back into hospital and ambulatory records systems.
Over time the company described its product as a set of AI agents embedded in health-system workflows. The agents build what Kouper calls longitudinal patient maps, which pull together information about a patient from across different care settings, and they connect natively to electronic health records.
Kouper's health-system customers include LifePoint, which expanded its partnership across several hospitals, Henry Ford Health's Mosaic Clinically Integrated Network, and Ascension Saint Thomas, which has been piloting the platform at its Nashville Midtown site, according to Unite.AI.
“We have extraordinary clinicians, but we can't solve access and continuity problems by asking them to do more.”
What Ellipsis brings
Ellipsis sells Sage, an AI care manager that works over the phone and through text messages. Sage handles care-management enrollment, clinical assessments such as the PHQ-9 and GAD-7 depression and anxiety questionnaires, medication adherence checks and outreach after a patient is discharged, HIT Consultant reported.
The product runs on what Ellipsis calls its Empathy Engine, a patented system trained on more than 3 million labeled clinical conversations that analyzes vocal cues in real time. Ellipsis says seven of the top 20 US health plans use it, along with academic medical centers and integrated delivery networks.
The company reports results from its deployments that include program enrollment six times faster, a 60% cut in administrative tasks, task completion rates up to 66% higher than those of human agents and a return on investment of up to seven times. These figures come from Ellipsis and were not independently verified.
Why Ellipsis is buying
The deal is meant to connect Sage's conversations with the systems where care is actually scheduled and recorded. With Kouper's EHR integrations, Sage will be able to draw on a patient's history, match at-risk patients with in-network providers and book appointments directly in host records systems such as Epic, Oracle Health and athenahealth, according to HIT Consultant.
For health plans, the companies said, the combination means a member's care can be coordinated from the first outreach call through to a confirmed appointment. Ellipsis framed the purchase as a shift away from one-off interactions toward continuous support across a patient's journey.
Mainul Mondal, Ellipsis's founder and chief executive, said the company could not fix gaps in access and continuity by asking its clinicians to take on more work, and that Kouper supplied the infrastructure needed to do that inside health systems. Salman Ali, Kouper's co-founder and chief executive, said the company was built to put AI directly into workflows and coordinate care over time.
The companies pointed to rising adoption of AI by providers: 75% of health systems have deployed at least one AI tool, up from 59% a year earlier, the release said.
The founders and the funding
Kouper is led by Ali. It came out of stealth in May 2025 with $10 million from General Catalyst, 25Madison and CVS Health Ventures, the venture arm of CVS Health, along with several angel investors, HC Innovation Group reported. A VC Backed profile lists that money as a Series A round. No lead investor was named, and no later funding has been reported.
Ellipsis raised a $45 million Series A in June 2025 led by Salesforce, Khosla Ventures and CVS Health Ventures, according to Unite.AI. That makes CVS Health Ventures an investor in both companies before the deal.
Unite.AI noted that the main question now is whether two separately branded products can be run as one reliable workflow while both continue to serve their own customers.
